Table 1

Grade 5 adverse events

Placebo + HDAC (N = 86)
Laromustine + HDAC (N = 177)
n%n%
Adverse events with death 11 13% 71 40% 
    Infectious deaths 3% 49 28% 
    Pulmonary deaths 0% 15 8% 
Placebo + HDAC (N = 86)
Laromustine + HDAC (N = 177)
n%n%
Adverse events with death 11 13% 71 40% 
    Infectious deaths 3% 49 28% 
    Pulmonary deaths 0% 15 8% 

N indicates number of patients; and n, number of deaths.